Start now and stick with it

The sooner you start STIOLTO RESPIMAT, the better

It's important to talk to your doctor and set up a treatment plan. Since COPD is a chronic disease, it can only get worse over time. While no medication can reverse COPD, STIOLTO RESPIMAT can significantly improve your breathing.

In clinical studies, people who took STIOLTO were able to improve their breathing all day and night. The sooner you make STIOLTO part of your daily routine, the sooner you could put better breathing back within reach.

Find out why a steroid-free medication was important to Bob

32 seconds
Tips on making STIOLTO
part of your life

Take 2 puffs of your STIOLTO RESPIMAT inhaler every day, at the same time

  • Helps keep your airways open for a full 24 hours
  • Refill your prescription on time so there’s no lapse in treatment
  • Taking STIOLTO as directed could decrease your rescue inhaler use

STIOLTO is not for sudden COPD symptoms. Always carry a rescue inhaler.

Stick with your treatment with RespiPoints™

This free support program is a great way for people taking STIOLTO RESPIMAT to get the most out of their COPD treatment.

Join RespiPoints™ today!

  • Earn points daily for taking your STIOLTO RESPIMAT and more
  • Redeem your earned points for e-gift cards for top retailers
  • Track your medication and know when it's time to refill your prescription
  • Easily link your STIOLTO RESPIMAT Savings Card to also earn points

APPROVED USE

STIOLTO® RESPIMAT® (tiotropium bromide and olodaterol) Inhalation Spray is a prescription medicine used long term, 2 puffs once each day, in controlling symptoms in adults with chronic obstructive pulmonary disease (COPD). COPD is a chronic lung disease that includes chronic bronchitis, emphysema, or both.

STIOLTO is not for treating sudden symptoms of COPD. Always have a rescue medicine with you to treat sudden symptoms.

Do not use STIOLTO if you have asthma.

IMPORTANT SAFETY INFORMATION

People with asthma who take long-acting beta2-agonist (LABA) medicines, such as olodaterol (one of the medicines in STIOLTO), have an increased risk of death from asthma problems. It is not known if LABA medicines, such as olodaterol, increase the risk of death in people with COPD. STIOLTO is approved for COPD only. STIOLTO is NOT to be used in asthma.

More Important Safety Information

APPROVED USE

STIOLTO® RESPIMAT® (tiotropium bromide and olodaterol) Inhalation Spray is a prescription medicine used long term, 2 puffs once each day, in controlling symptoms in adults with chronic obstructive pulmonary disease (COPD). COPD is a chronic lung disease that includes chronic bronchitis, emphysema, or both.

STIOLTO is not for treating sudden symptoms of COPD. Always have a rescue medicine with you to treat sudden symptoms.

Do not use STIOLTO if you have asthma.

 

IMPORTANT SAFETY INFORMATION

IMPORTANT SAFETY INFORMATION (cont'd)

People with asthma who take long-acting beta2-agonist (LABA) medicines, such as olodaterol (one of the medicines in STIOLTO), have an increased risk of death from asthma problems. It is not known if LABA medicines, such as olodaterol, increase the risk of death in people with COPD. STIOLTO is approved for COPD only. STIOLTO is NOT to be used in asthma.

Do not use STIOLTO if you are allergic to tiotropium, ipratropium, atropine or similar drugs, olodaterol, or any ingredient in STIOLTO. Call your healthcare provider or get emergency medical care if you experience symptoms of a serious allergic reaction including: rash, hives, itching, swelling of the face, lips, tongue, throat, and breathing problems.

Do not use STIOLTO for treating sudden breathing problems. Always have a rescue inhaler with you to treat sudden symptoms.

Get emergency medical care if your breathing problems worsen quickly or if you use your rescue inhaler but it does not relieve your breathing problems. Call your healthcare provider if breathing problems worsen over time while using STIOLTO.

Do not use STIOLTO more often than prescribed by your doctor. Do not use STIOLTO with other LABAs or anticholinergics.

Tell your doctor about all the medicines you take, including prescription and over-the-counter medicines, eye drops, vitamins, and herbal supplements. STIOLTO may interact with other medicines which may cause serious side effects.

Tell your doctor about all your medical conditions including heart problems, high blood pressure, seizures, thyroid problems, diabetes, kidney problems, glaucoma, enlarged prostate, and problems passing urine.

STIOLTO can cause serious side effects, including sudden shortness of breath that may be life threatening, fast or irregular heartbeat, increased blood pressure, chest pain, high blood sugar, or low blood potassium that may cause muscle spasms or weakness or abnormal heart rhythm. If any of these happens, stop taking STIOLTO and seek immediate medical help.

STIOLTO can cause new or worsening eye problems including narrow-angle glaucoma, and can increase the pressure in your eyes, which can cause the following symptoms: eye pain, blurred vision, seeing halos or colored images along with red eyes. If you have any of these symptoms, stop taking STIOLTO and call your doctor right away.

STIOLTO can cause new or worsened urinary retention. Symptoms of urinary retention may include difficulty passing urine, painful urination, urinating frequently, or urinating in a weak stream or drips. If you have any of these symptoms, stop taking STIOLTO and call your doctor right away.

The most common side effects of STIOLTO are runny nose, cough, and back pain.

STIOLTO is for oral inhalation only.

The STIOLTO cartridge is only intended for use with the STIOLTO RESPIMAT inhaler.

Do not spray STIOLTO into your eyes. Your vision may become blurred and your pupils may become larger (dilated).

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.FDA.gov/medwatch or call 1‑800‑FDA‑1088.

Read the step-by-step patient Instructions for Use for STIOLTO RESPIMAT before you use your inhaler.

Please see accompanying Medication Guide, Instructions for Use, and full Prescribing Information, including boxed WARNING.

CL-STO-100003 10.11.2018